BHI Weekly News Archives 133rd Edition – January 14, 2015 You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing…Super UserJanuary 14, 2015
News AstraZeneca plc: MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into…Super UserJanuary 13, 2015
News Angel investor tax credit could make Maryland more appealing to investors, entrepreneurs – Baltimore Business Journal Washington, D.C., Philadelphia, New York — Maryland has a lot of competition for entrepreneurs' attention.…Super UserJanuary 13, 2015
News Qiagen (QGEN) Launches Next-Gen TB Infection Test – Zacks.com Sample and assay technologies provider Qiagen NV recently announced the launch of its latest diagnostic…Super UserJanuary 13, 2015
News Alexandria Real Estate seeking to raise $20 million to back digital health in S.F. – The Technology Chronicles Alexandria Real Estate Equities, the real estate firm that helped transform Mission Bay into a…Super UserJanuary 13, 2015
News Human genome pioneer J. Craig Venter taps Baltimore startup for next project – Baltimore Business Journal J. Craig Venter was one of the first scientists in 2001 to map the human…Super UserJanuary 13, 2015
News BD Intelliport IV Medication Management System Cleared by FDA (VIDEO) BD Medical, a part of Becton, Dickinson and Company, announced receiving FDA clearance for its Intelliport…Super UserJanuary 13, 2015
BHI Weekly News Archives 132nd Edition – January 13, 2015 – Year in Review You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing…Super UserJanuary 13, 2015
News Qualcomm and Novartis Part 2: Let’s start an investment company The Beyond the Pill movement took an interesting turn this week when Qualcomm announced plans…Super UserJanuary 12, 2015
News AstraZeneca – MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into…Super UserJanuary 12, 2015